Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.
Saved in:
| Title: | Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. |
|---|---|
| Authors: | Wijkstra, J. (AUTHOR), Burger, H. (AUTHOR), Van Den Broek, W. W. (AUTHOR), Birkenhäger, T. K. (AUTHOR), Janzing, J. G. E. (AUTHOR), Boks, M. P. M. (AUTHOR), Bruijn, J. A. (AUTHOR), Van Der Loos, M. L. M. (AUTHOR), Breteler, L. M. T. (AUTHOR), Ramaekers, G. M. G. I. (AUTHOR), Verkes, R. J. (AUTHOR), Nolen, W. A. (AUTHOR) |
| Source: | Acta Psychiatrica Scandinavica. Mar2010, Vol. 121 Issue 3, p190-200. 11p. 1 Diagram, 3 Charts, 2 Graphs. |
| Subjects: | Psychotic depression, Antidepressants, Imipramine, Venlafaxine, Mental health, Therapeutics |
| Abstract: | Wijkstra J, Burger H, van den Broek WW, Birkenhäger TK, Janzing JGE, Boks MPM, Bruijn JA, van der Loos MLM, Breteler LMT, Ramaekers GMGI, Verkes RJ, Nolen WA. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. Objective: It remains unclear whether unipolar psychotic depression should be treated with an antidepressant and an antipsychotic or with an antidepressant alone. Method: In a multi-center RCT, 122 patients (18–65 years) with DSM-IV-TR psychotic major depression and HAM-D-17 ≥ 18 were randomized to 7 weeks imipramine (plasma-levels 200–300 μg/l), venlafaxine (375 mg/day) or venlafaxine–quetiapine (375 mg/day, 600 mg/day). Primary outcome was response on HAM-D-17. Secondary outcomes were response on CGI and remission (HAM-D-17). Results: Venlafaxine–quetiapine was more effective than venlafaxine with no significant differences between venlafaxine–quetiapine and imipramine, or between imipramine and venlafaxine. Secondary outcomes followed the same pattern. Conclusion: That unipolar psychotic depression should be treated with a combination of an antidepressant and an antipsychotic and not with an antidepressant alone, can be considered evidence based with regard to venlafaxine–quetiapine vs. venlafaxine monotherapy. Whether this is also the case for imipramine monotherapy is likely, but cannot be concluded from the data. [ABSTRACT FROM AUTHOR] |
| Copyright of Acta Psychiatrica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 47952710 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Wijkstra%2C+J%2E%22">Wijkstra, J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burger%2C+H%2E%22">Burger, H.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Van+Den+Broek%2C+W%2E+W%2E%22">Van Den Broek, W. W.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Birkenhäger%2C+T%2E+K%2E%22">Birkenhäger, T. K.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Janzing%2C+J%2E+G%2E+E%2E%22">Janzing, J. G. E.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boks%2C+M%2E+P%2E+M%2E%22">Boks, M. P. M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bruijn%2C+J%2E+A%2E%22">Bruijn, J. A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Van+Der+Loos%2C+M%2E+L%2E+M%2E%22">Van Der Loos, M. L. M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Breteler%2C+L%2E+M%2E+T%2E%22">Breteler, L. M. T.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ramaekers%2C+G%2E+M%2E+G%2E+I%2E%22">Ramaekers, G. M. G. I.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verkes%2C+R%2E+J%2E%22">Verkes, R. J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nolen%2C+W%2E+A%2E%22">Nolen, W. A.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Acta+Psychiatrica+Scandinavica%22">Acta Psychiatrica Scandinavica</searchLink>. Mar2010, Vol. 121 Issue 3, p190-200. 11p. 1 Diagram, 3 Charts, 2 Graphs. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Psychotic+depression%22">Psychotic depression</searchLink><br /><searchLink fieldCode="DE" term="%22Antidepressants%22">Antidepressants</searchLink><br /><searchLink fieldCode="DE" term="%22Imipramine%22">Imipramine</searchLink><br /><searchLink fieldCode="DE" term="%22Venlafaxine%22">Venlafaxine</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+health%22">Mental health</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Wijkstra J, Burger H, van den Broek WW, Birkenhäger TK, Janzing JGE, Boks MPM, Bruijn JA, van der Loos MLM, Breteler LMT, Ramaekers GMGI, Verkes RJ, Nolen WA. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. Objective: It remains unclear whether unipolar psychotic depression should be treated with an antidepressant and an antipsychotic or with an antidepressant alone. Method: In a multi-center RCT, 122 patients (18–65 years) with DSM-IV-TR psychotic major depression and HAM-D-17 ≥ 18 were randomized to 7 weeks imipramine (plasma-levels 200–300 μg/l), venlafaxine (375 mg/day) or venlafaxine–quetiapine (375 mg/day, 600 mg/day). Primary outcome was response on HAM-D-17. Secondary outcomes were response on CGI and remission (HAM-D-17). Results: Venlafaxine–quetiapine was more effective than venlafaxine with no significant differences between venlafaxine–quetiapine and imipramine, or between imipramine and venlafaxine. Secondary outcomes followed the same pattern. Conclusion: That unipolar psychotic depression should be treated with a combination of an antidepressant and an antipsychotic and not with an antidepressant alone, can be considered evidence based with regard to venlafaxine–quetiapine vs. venlafaxine monotherapy. Whether this is also the case for imipramine monotherapy is likely, but cannot be concluded from the data. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Acta Psychiatrica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=47952710 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/j.1600-0447.2009.01464.x Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 190 Subjects: – SubjectFull: Psychotic depression Type: general – SubjectFull: Antidepressants Type: general – SubjectFull: Imipramine Type: general – SubjectFull: Venlafaxine Type: general – SubjectFull: Mental health Type: general – SubjectFull: Therapeutics Type: general Titles: – TitleFull: Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wijkstra, J. – PersonEntity: Name: NameFull: Burger, H. – PersonEntity: Name: NameFull: Van Den Broek, W. W. – PersonEntity: Name: NameFull: Birkenhäger, T. K. – PersonEntity: Name: NameFull: Janzing, J. G. E. – PersonEntity: Name: NameFull: Boks, M. P. M. – PersonEntity: Name: NameFull: Bruijn, J. A. – PersonEntity: Name: NameFull: Van Der Loos, M. L. M. – PersonEntity: Name: NameFull: Breteler, L. M. T. – PersonEntity: Name: NameFull: Ramaekers, G. M. G. I. – PersonEntity: Name: NameFull: Verkes, R. J. – PersonEntity: Name: NameFull: Nolen, W. A. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2010 Type: published Y: 2010 Identifiers: – Type: issn-print Value: 0001690X Numbering: – Type: volume Value: 121 – Type: issue Value: 3 Titles: – TitleFull: Acta Psychiatrica Scandinavica Type: main |
| ResultId | 1 |